News
Variation in Make-Up of Generic Epilepsy Drugs Can Lead to Dosing Problems - 06/29/2011
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns
Japan to become the next ‘hub’ for generic drugs market says new report | PRLog
Japan to become the next ‘hub’ for generic drugs market says new report. Piribo, the online destination for Pharma intelligence, has added a new report. - PR11799791
Process Analytical Technology | Watson Commits to PAT and QbD for Generic Drug Development |
Watson Pharmaceuticals, Inc. announced plans to establish a Global R&D Technology Center in North Brunswick, New Jersey. The Company has signed a lease for a 32,000-square-foot facility at the New Jersey Economic Development Authority's Technology Centre of New Jersey, a 50-acre complex consisting
Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.
Biotech Buyout Portfolio: Momenta Pharmaceuticals - Seeking Alpha
< strong > By < a href='http://bulwatechreport.com/blog/' > Steven Bulwa < /a > : < /strong > < blockquote class="quote" > < p > Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the characterization and process engineering of complex molecules. These complex molecules include
Pfizer and Eli Lilly face generic drugs challenge - FT.com
Pfizer and Eli Lilly felt the effects of their “patent cliffs” during the final three months of last year, as fourth-quarter profits were weighed down by the impact of their top drugs facing new competition from generics. Pfizer, the world’s largest
Pfizer Inc Lipitor Plan Might Not Be Worth It
Pfizer Inc. ’s strategy to keep its market share of cholesterol pill Lipitor may boost revenue without aiding profit, said the chief executive officer
Views from Pharma Leaders: A Year in Review and a Look Forward - Pharmaceutical Technology
Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry.
Development and Commercialization of Biosimilars in India - The author aims to present the current
The author explains the current status of India, the challenges, and recommendations that may alleviate these challenges.
amednews: Supreme Court hears arguments in drug patent cases :: Dec. 19, 2011 ... American Medical
Rulings could impact how physicians are able to provide certain lab tests and prescribe certain drug uses.
Refine by Content Type:
Refine by Source:
- pharmtech.findpharma.com (93)
- www.prlog.org (92)
- www.thelancet.com (45)
- seekingalpha.com (33)
- finance.yahoo.com (20)
- www.dddmag.com (19)
- download.thelancet.com (16)
- www.medpagetoday.com (12)
- www.pharmamanufacturing.com (11)
- www.ft.com (10)
- www.prweb.com (10)
- biopharminternational.findpharma.com (9)
